跳至主要内容
临床试验/NCT05184504
NCT05184504已完成不适用

Renal Cell Cancer Registry in Latin American Clinical-phatological Characterization and Outcomes of Renal Cell Carcinoma in Latin America

Latin American Cooperative Oncology Group16 个研究点 分布在 1 个国家目标入组 211 人开始时间: 2022年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
211
试验地点
16
主要终点
Build a real-life renal cell cancer database in Brazil and Latin America

研究概览

简要总结

Observational study, retrospective and prospective, of an analytical nature. Data will be collected from medical records and/or through contact with physicians and institutions (secondary data collection). Patients included retrospectively or prospectively will be followed during the data collection period for the evaluation of treatments and survival. No intervention is planned in this protocol.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients ≥ 18 years of age;
  • Proven histology of renal cell carcinoma (any subtype);
  • Pathological diagnosis of renal cell carcinoma in January 2015 or later and new cases diagnosed during the period of recruitment of each center;
  • Have the medical record available and suitable for collecting data on patient characteristics, treatment and outcome.

排除标准

  • Synchronous or other primary tumor within the last 3 years (except thyroid cancer or non melanoma skin).

结局指标

主要结局

Build a real-life renal cell cancer database in Brazil and Latin America

时间窗: 2022

次要结局

  • Progression-free survival in each therapeutic line(2022)
  • Causes of delay or discontinuation of each treatment checklist(2022)
  • Time between diagnosis and start of treatment.(2022)
  • Overall survival(2022)
  • Clinicopathological characteristics of patients with renal cell cancer checklist(2022)
  • Sociodemographic characteristics checklist(2022)
  • Characteristics of systemic treatment checklist(2022)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (16)

Loading locations...

相似试验